3564-85-0 Usage
Uses
Used in Pharmaceutical Industry:
[6aS,(+)]-6a,12aα-Dihydro-2,3,9-trimethoxy[1]benzopyrano[3,4-b][1]benzopyran-12(6H)-one is used as a potential pharmaceutical candidate for [application reason] due to its complex molecular structure and potential biological activity.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, [6aS,(+)]-6a,12aα-Dihydro-2,3,9-trimethoxy[1]benzopyrano[3,4-b][1]benzopyran-12(6H)-one is used as a subject of study for [application reason] because of its unique molecular characteristics and the possibility of discovering new therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 3564-85-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,5,6 and 4 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 3564-85:
(6*3)+(5*5)+(4*6)+(3*4)+(2*8)+(1*5)=100
100 % 10 = 0
So 3564-85-0 is a valid CAS Registry Number.
InChI:InChI=1/C19H18O6/c1-21-10-4-5-11-14(6-10)25-17-9-24-13-8-16(23-3)15(22-2)7-12(13)18(17)19(11)20/h4-8,17-18H,9H2,1-3H3/t17-,18+/m1/s1
3564-85-0Relevant academic research and scientific papers
Synthetic Modulation of the Peripheral 2-, 3-, 9- and 12-Oxygenation Pattern of Rotenoids
Crombie, Leslie,Josephs, Jonathan L.
, p. 2591 - 2598 (2007/10/02)
Synthetic modulations of the rotenoid munduserone, in terms of the peripheral oxygenation pattern, have been carried out for structure-activity purposes.Synthesis by propargyl Claisen rearrangement was successful in cases having 2,3-dimethoxylation in ring A (as in natural Leguminous rotenoids), but failed when this electron release was not present.Attempts to catalyse an unsuccessful case led instead to an alkylidenedihydrobenzofuranone.The rotenoid lacking 2,3-dimethoxylation was made by chromanone β-ester synthesis, as was the parent rotenoid of the Boerhaavia (monocotyledonous) group.The rotenoid 12-carbonyl can be removed by reduction and dehydration, and the resulting stilbene, when catalytically hydrogenated, gives the cis-B/C-12-deoxy compound.When the reduction is effected by dissolving magnesium in methanol a separable mixture of cis- and trans-12-deoxyrotenoids is obtained.
